The decision comes one day after an advisory panel voted 15-0 to recommend clearing another step for a potential second option for the youth population. A week before, an FDA panel voted 22-0 June 14 recommending Moderna’s vaccine for children as young as 6.
Both Pfizer and Moderna’s vaccines are authorized nationally for Americans as young as 6 months old.
